Development and implementation of a Monte Carlo frame work for evaluation of patient specific out- of - field organ equivalent dose

Background: The aim of this study was to develop and implement a Monte Carlo framework for evalua on of pa ent specific out-of-field organ equivalent dose (OED). Materials and Methods: Dose calcula ons were performed using a Monte Carlo-based model of Oncor linac and tomographic phantoms. Monte Carlo simula ons were performed using EGSnrc user codes. Dose measurements were performed using radiochromic films. Furthermore, the applicability of this framework was examined for a 3D conformal radiotherapy of breast. Results: Commissioning of the beam model was done by comparing the measured and calculated out-of-field dose values of several points in the physical and tomographic phantoms, respec vely. The maximum percentage difference was 17%, which was smaller than 30% acceptance criteria for Monte Carlo modeling. The maximum sta s cal uncertainty in out -of-field dose calcula on was 23%. Organ equivalent doses for out of field organs in 3D conformal radiotherapy of le1 breast varied from 2.4 cGy for right kidney to 134.6 cGy for the le1 humeral head. Conclusion: The framework developed in this research is a valuable tool for calcula ng peripheral dose and out-of field pa ent specific OEDs, the quan es needed for calcula ng risk of secondary cancer induc on as a result of radiotherapy. This code can be used as a pa ent specific treatment plan op miza on tool in order to select a treatment plan with the lowest risk of secondary cancer induc on.

[1]  B. Bednarz,et al.  A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models. , 2010, Medical physics.

[2]  M. Musthafa,et al.  Out-of-field photon dosimetry study between 3-D conformal and intensity modulated radiation therapy in the management of prostate cancer , 2015 .

[3]  E. Sham,et al.  Precise radiochromic film dosimetry using a flat-bed document scanner. , 2005, Medical physics.

[4]  J. Ruben,et al.  The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. , 2008, International journal of radiation oncology, biology, physics.

[5]  P. Evans,et al.  Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer. , 2012, Medical physics.

[6]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[7]  Joseph O Deasy,et al.  CERR: a computational environment for radiotherapy research. , 2003, Medical physics.

[8]  M. Atarod,et al.  Out-of-field beam characteristics of a 6 MV photon beam: results of a Monte Carlo study. , 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[9]  S. Zavgorodni,et al.  Absolute dose calculations for Monte Carlo simulations of radiotherapy beams , 2005, Physics in medicine and biology.

[10]  Division on Earth Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 , 2006 .

[11]  M. Atarod,et al.  Monte Carlo Study of Fetal Dosimetry Parameters for 6 MV Photon Beam , 2013, Journal of medical signals and sensors.

[12]  Harald Paganetti,et al.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction , 2008, Physics in medicine and biology.

[13]  B Mijnheer,et al.  Tolerances for the accuracy of photon beam dose calculations of treatment planning systems. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Gary D Fullerton,et al.  Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. , 2006, Medical physics.